Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Strategic Long Term, Immunologically Driven Treatment Interruptions in Patients on Effective HAART: a Controlled, Randomized Study

NCT00310245 is registered in ClinicalTrials.gov with A.O. Ospedale Papa Giovanni XXIII as lead sponsor.

NCT NCT00310245
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00310245 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Strategic Long Term, Immunologically Driven Treatment Interruptions in Patients on Effective HAART: a Controlled, Randomized Study
Lead sponsor
A.O. Ospedale Papa Giovanni XXIII
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2000
Completion date
November 30, 2005
Enrollment
130
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infection